The role of CD8 and CD4 T cells in intestinal allograft rejection: A comparison of monoclonal antibody-treated and knockout mice

Transplantation

Volumn 67, Issue 1, 1999, Pages 131-137

  He, Gang ^a   Hart, John ^a   Kim, Oliver S ^a   Szot, Gregory L ^a   Siegel, Christopher T ^a   Thistlethwaite, J Richard ^a   Newell, Kenneth A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; OKT 4; OKT 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CONTROLLED STUDY; EXPERIMENTAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; INTESTINE GRAFT; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; T LYMPHOCYTE SUBPOPULATION;

EID: 0033556457     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00022     Document Type: Article

References (34)

1. Ingham Clark CL, Lear PA, Wood S, Lennard-Jones JE, Wood RF. Potential candidates for small bowel transplantation. Br J Surg 1992; 79: 676.
2. Colomb V, De Potter S, Goulet O, et al. Potential candidates for small bowel transplantation in pediatric patients on home parenteral nutrition. Transplant Proc 1996; 28: 2698.
3. Balzola F, De Francesco A, Boggio Bertinet D, Fadda M, Balzola FA. The Italian need for intestinal transplantation. Transplant Proc 1997; 29: 1792.
4. Grant D. Current results of intestinal transplantation: the International Intestinal Transplant Registry. Lancet 1996; 347: 1801.
5. Clark CL. The immune response in small bowel transplantation. Ann R Coll Surg Engl 1996; 78: 97.
6. Squiers EC, Kelley SE, West JC. Small bowel transplantation in the mouse: development of a model. Microsurgery 1992; 13: 345.
7. Zhong R, Zhang Z, Quan D, Duff J, Stiller C, Grant D. Development of a mouse intestinal transplantation model. Microsurgery 1993; 14: 141.
8. Quan D, Grant DR, Zhong RZ, Zhang Z, Garcia BM, Jevnikar AM. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection. Transplantation 1994; 58: 808.
9. Chen H, Qi S, Xu D, Wu J, Daloze P. The immunosuppressive effect of rapamycin on mouse small bowel transplantation. Transplantation 1996; 61: 523.
10. Newell KA, He G, Hart J, Thistlethwaite JR Jr. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation 1997; 64: 959.
11. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 1984; 312: 548.
12. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
13. Billiar TR, Garberoglio C, Schraut WH. Maltose absorption as an indicator of small-intestinal allograft rejection. J Surg Res 1984; 37: 75.
14. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature 1990; 344: 742.
15. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 1991; 253: 1417.
16. Langrehr JM, Banner B, Lee KK, Schraut WH. Clinical course, morphology, and treatment of chronically rejecting small bowel allografts. Transplantation 1993; 55: 242.
17. 1996 annual report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network. Transplant data: 1988-1995. Richmond, VA: United Network of Organ Sharing, and Rockville, MD: Division of Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, US Department of Health and Human Services, 1996.
18. Asfar S, Zhong R, Grant D. Small bowel transplantation. Surg Clin North Am 1994; 74: 1197.
19. Todo S, Reyes J, Furukawa H, et al. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995; 222: 270.
20. Zhang Z, Zhu L, Quan D, et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267.
21. Bishop DK, Chan S, Li W, Ensley RD, Xu S, Eichwald EJ. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56: 892.
22. Morton AL, Bell EB, Bolton EM, et al. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody. Eur J Immunol 1993; 23: 2078.
23. Yokoi Y, Sumimoto R, Yamaguchi A, Baba S, Nakamura S, Kimura H. Role of T-cell subsets in rat liver allograft rejection. Transplant Proc 1993; 25: 1994.
24. Yin DP, Sankary HN, Williams J, Krieger N, Fathman CG. Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig. Transplantation 1996; 62: 1537.
25. Bowles MJ, Webster GA, Wood RF, Pockley AG. Effect of anti-CD4 monoclonal antibody therapy on rat small bowel allograft survival. Transplant Proc 1994; 26: 1605.
26. Mannon RB, Nataraj C, Kotzin BL, et al. Rejection of kidney allografts by MHC class I-deficient mice. Transplantation 1995; 59: 746.
27. Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 3373.
28. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
29. VanBuskirk AM, Wakely ME, Orosz CG. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations. Transplantation 1996; 62: 300.
30. Shelton MW, Walp LA, Basler JT, Uchiyama K, Hanto DW. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells. Transplantation 1992; 54: 278.
31. Binder J, Lehmann M, Graser E, et al. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation 1996; 61: 804.
32. Lehmann M, Graser E, Risch K, et al. Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 1997; 64: 1181.
33. Chan SY, DeBruyne LA, Goodman RE, Eichwald EJ, Bishop DK. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155.
34. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate: comparison with anti-CD4 monoclonal antibody. Transplantation 1996; 61: 783.